135 related articles for article (PubMed ID: 11230000)
1. Cutaneous vasculitis induced by paroxetine.
Margolese HC; Chouinard G; Beauclair L; Rubino M
Am J Psychiatry; 2001 Mar; 158(3):497. PubMed ID: 11230000
[No Abstract] [Full Text] [Related]
2. Paroxetine-induced enuresis.
Toros F; Erdoğan K
Eur Psychiatry; 2003 Feb; 18(1):43-4. PubMed ID: 12648899
[No Abstract] [Full Text] [Related]
3. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
Kamijima K; Aoki M
Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
[TBL] [Abstract][Full Text] [Related]
4. Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder.
Heiden A; de Zwaan M; Frey R; Presslich O; Kasper S
J Psychiatry Neurosci; 1998 May; 23(3):179-80. PubMed ID: 9595892
[No Abstract] [Full Text] [Related]
5. High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.
Sasayama D; Sugiyama N; Imai J; Hayashida A; Harada Y; Amano N
Psychiatry Clin Neurosci; 2009 Apr; 63(2):251. PubMed ID: 19335398
[No Abstract] [Full Text] [Related]
6. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine: a review of clinical experience.
Dunner D; Kumar R
Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236
[TBL] [Abstract][Full Text] [Related]
8. A Case of Cutaneous Leukocytoclastic Vasculitis Associated With Aripiprazole.
Keshavarz-Akhlaghi AA; Abdollahpour E; Seddigh R
Prim Care Companion CNS Disord; 2016 Aug; 18(4):. PubMed ID: 27828707
[No Abstract] [Full Text] [Related]
9. Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder.
Findling RL; Nucci G; Piergies AA; Gomeni R; Bartolic EI; Fong R; Carpenter DJ; Leeder JS; Gaedigk A; Danoff TM
Neuropsychopharmacology; 2006 Jun; 31(6):1274-85. PubMed ID: 16319918
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of paroxetine with clocapramine in panic disorder.
Saito M; Miyaoka H
Psychiatry Clin Neurosci; 2007 Aug; 61(4):449. PubMed ID: 17610675
[No Abstract] [Full Text] [Related]
11. Exacerbation of extrapyramidal symptoms with paroxetine.
Arya DK; McKenzie J; Worrall N
Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063
[No Abstract] [Full Text] [Related]
12. A case of paroxetine-induced akathisia.
Olivera AA
Biol Psychiatry; 1996 May; 39(10):910. PubMed ID: 8860197
[No Abstract] [Full Text] [Related]
13. Withdrawal after discontinuation of paroxetine.
Arya DK
Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183
[No Abstract] [Full Text] [Related]
14. Late-onset obsessive-compulsive disorder: the role of stressful life events.
Velayudhan L; Katz AW
Int Psychogeriatr; 2006 Jun; 18(2):341-4. PubMed ID: 16420720
[TBL] [Abstract][Full Text] [Related]
15. [Narcoleptic syndrome as a possible side effect of paroxetine].
Alonso H; Ortí-Pareja M; Jiménez-Jiménez FJ
Rev Neurol; 2004 Dec 1-15; 39(11):1092. PubMed ID: 15597274
[No Abstract] [Full Text] [Related]
16. Paroxetine-induced bruxism effectively treated with tandospirone.
Kishi Y
J Neuropsychiatry Clin Neurosci; 2007; 19(1):90-1. PubMed ID: 17308240
[No Abstract] [Full Text] [Related]
17. Antidepressant-related hypomania in a patient with premenstrual dysphoric disorder.
Hsiao MC; Liu CY
J Clin Psychopharmacol; 2002 Oct; 22(5):534-5. PubMed ID: 12352284
[No Abstract] [Full Text] [Related]
18. Lower gastrointestinal bleeding and paroxetine use: two case reports.
Blasco-Fontecilla H; de Leon J
Psychosomatics; 2012; 53(2):184-7. PubMed ID: 22424167
[No Abstract] [Full Text] [Related]
19. Toxic epidermal necrolysis after paroxetine treatment.
Ahmed R; Eagleton C
N Z Med J; 2008 May; 121(1274):86-9. PubMed ID: 18535650
[TBL] [Abstract][Full Text] [Related]
20. Putting GlaxoSmithKline to the test over paroxetine.
Doshi P
BMJ; 2013 Nov; 347():f6754. PubMed ID: 24222673
[No Abstract] [Full Text] [Related]
[Next] [New Search]
